MEDP Stock: Price, Earnings History and SEC Filings
Medpace Holdings, Inc. (MEDP) last traded at $652.01, down 3.77% on the latest session and up 4.5% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $4.84 against an analyst estimate of $4.45, a beat of 8.8%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MEDP earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 21, 2026 | $4.84 | $4.45 | +8.76% |
| Jun 2026 | Jul 22, 2026 | $4.25 | $4.08 | +4.17% |
| Mar 2026 | Apr 22, 2026 | $4.28 | $3.74 | +14.44% |
| Dec 2025 | Feb 9, 2026 | $4.67 | $4.18 | +11.72% |
MEDP beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How MEDP reacts to earnings
Across its last 8 earnings releases, MEDP moved 16.0% on average the next session, in either direction. It rose after 3 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-21 | After close | -1.29% |
| 2026-07-22 | After close | +14.71% |
| 2026-04-22 | After close | -22.63% |
| 2026-02-09 | After close | -15.90% |
| 2025-10-22 | After close | +9.12% |
| 2025-07-21 | After close | +54.67% |
| 2025-04-21 | After close | -2.32% |
| 2025-02-10 | After close | -7.52% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
MEDP financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2.5B | $451M | $682M | 17.8% | $15.28 |
| 2024 | $2.1B | $404M | $572M | 19.2% | $12.63 |
| 2023 | $1.9B | $283M | $397M | 15.0% | $8.88 |
| 2022 | $1.5B | $245M | $351M | 16.8% | $7.28 |
| 2021 | $1.1B | $182M | $235M | 15.9% | $4.81 |
| 2020 | $926M | $145M | $227M | 15.7% | $3.84 |
| 2019 | $861M | $100M | $184M | 11.7% | $2.67 |
| 2018 | $705M | $73M | $141M | 10.4% | $1.97 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for MEDP
- 10-Q · Oct 22, 2026
- 8-K · Oct 21, 2026Results of operations, Other events, Financial statements and exhibits
- 10-Q · Jul 23, 2026
- 8-K · Jul 22, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 4, 2026Officer or director change
- 8-K · May 19, 2026Bylaw change, Shareholder vote, Financial statements and exhibits
- 10-Q · Apr 23, 2026
- 8-K · Apr 22, 2026Results of operations, Officer or director change, Financial statements and exhibits
- DEF 14A · Apr 1, 2026
- 10-K · Feb 10, 2026
Insider filing activity
MEDP insiders filed 26 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
MEDP news
- Medpace Holdings IncOct 31, 2026 · 247wallst.com
- 2 high-flying stocks on our watchlist and 1 we turn downOct 30, 2026 · finance.yahoo.com
- Medpace (MEDP) is a Great Momentum Stock: Should You Buy?Oct 30, 2026 · finance.yahoo.com
- RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin ClimbsOct 30, 2026 · finance.yahoo.com
- Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?Oct 29, 2026 · finance.yahoo.com
- 3 Reasons Growth Investors Will Love Vertiv (VRT)Oct 29, 2026 · msn.com
- Breakout Watch: 4 Reasons To Monitor This Top-Rated Medical StockOct 28, 2026 · finance.yahoo.com
- BSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock DownOct 28, 2026 · finance.yahoo.com
About Medpace Holdings, Inc.
Medpace Holdings, Inc. (MEDP) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-commercial Physical & Biological Research. It is incorporated in DE. Its fiscal year ends in December.